BackCASI Pharmaceuticals Overview

CASI Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for CASI.

Quarterly Cost of Revenue

$2.37M
↓ 36.79% YoY

As of Sep 30, 2025

Annual Cost of Revenue (TTM)

$17.23M
↑ 80.76% YoY

Trailing 12 months ending Sep 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin